Aurobindo Pharma Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
18.83 | 59.31 | -68.25% | 14.69 | +28.17% |
| P/S |
|
2.06 | 8.62 | -76.09% |
|
|
| P/BV |
|
2 | 6.53 | -69.35% |
|
|
| P/FCF |
|
-41.95 | 0.6184 | -6884.63% |
|
|
| Ev/Ebitda |
|
10.29 | 141.72 | -92.74% |
|
|
| Ev/S |
|
2.07 | 8.63 | -75.98% |
|
|
| Ev/FCF |
|
-54.81 | 7.72 | -810% |
|
|
| E/P |
|
0.069 | 0.1367 | -49.54% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
20.15 | 0.3647 | 5423.88% | 19.94 | +1.03% |
| ROE |
|
10.63 | 7.22 | 47.22% |
|
|
| ROA |
|
7.04 | 6.7 | 5.13% |
|
|
| ROIC |
|
6.82 | 15.91 | -57.13% |
|
|
| ROS |
|
10.94 | -4.66 | -334.52% |
|
|
| ROCE |
|
14.48 | 11.71 | 23.63% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
8/10
|
1.09 | 123.39 | -99.11% | 1.08 | +1.55% |
| Nеt Debt/Ebitda |
|
0.0632 | 121.88 | -99.95% |
|
|
| Debt/Ratio |
|
0.1419 | 0.1698 | -16.43% |
|
|
| Debt/Equity |
|
0.5119 | 3.45 | -85.14% |
|
|
| Debt/Net Income |
|
2.02 | 3.06 | -34.13% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
1.65/10
|
0.6559 | 9.59 | -93.16% | 0.837 | -21.64% |
| Number of years of dividend growth |
|
0 | 0.7073 | -100% | ||
| DSI |
|
0.8571 | 0.8351 | 2.64% |
|
|
| Average dividend growth |
|
-6.1 | -2.19 | 178.14% |
|
|
| Average percentage for 5 years |
|
0.837 | 14.83 | -94.36% |
|
|
| Average percentage for payments |
|
29.49 | 24.67 | 19.54% |
|
|
| Difference from average difference in sector |
|
-8.93 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
27.55 | 695.45 | -96.04% | ||
| Growth impulse Ebitda in 5 years |
|
18.72 | 617.6 | -96.97% | ||
| Growth impulse Net Income in 5 years |
|
11.52 | 759.48 | -98.48% | ||
| Growth impulse FCF in 5 years |
|
-137.18 | 1011.9 | -113.56% | ||
| Growth impulse EPS in 5 years |
|
12.11 | 220.4 | -94.51% |
IP Score
4.74/10
